These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11731354)

  • 1. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial.
    Michelson D; Allgulander C; Dantendorfer K; Knezevic A; Maierhofer D; Micev V; Paunovic VR; Timotijevic I; Sarkar N; Skoglund L; Pemberton SC
    Br J Psychiatry; 2001 Dec; 179():514-8. PubMed ID: 11731354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
    Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
    Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
    J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder.
    Emmanuel NP; Ware MR; Brawman-Mintzer O; Ballenger JC; Lydiard RB
    J Clin Psychiatry; 1999 May; 60(5):299-301. PubMed ID: 10362436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of comorbid premature ejaculation and panic disorder with fluoxetine.
    Kindler S; Dolberg OT; Cohen H; Hirschmann S; Kotler M
    Clin Neuropharmacol; 1997 Oct; 20(5):466-71. PubMed ID: 9331524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Pollack M; Lydiard RB; Tamura R; Tepner R; Tollefson G
    Br J Psychiatry; 1999 Mar; 174():213-8. PubMed ID: 10448445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine versus fluoxetine in the treatment of panic disorder.
    Ribeiro L; Busnello JV; Kauer-Sant'Anna M; Madruga M; Quevedo J; Busnello EA; Kapczinski F
    Braz J Med Biol Res; 2001 Oct; 34(10):1303-7. PubMed ID: 11593305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
    Tiller JW; Bouwer C; Behnke K
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of weekly treatment with enteric-coated fluoxetine in patients with major depressive disorder.
    Dinan TG
    J Clin Psychiatry; 2001; 62 Suppl 22():48-52. PubMed ID: 11599649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
    Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trial.
    Sedighi F; Zarghami M; Alizadeh Arimi F; Moosazadeh M; Ala S; Ghasemian R; Mehravaran H; Elyasi F
    Neuropsychopharmacol Rep; 2023 Jun; 43(2):202-212. PubMed ID: 36941089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice.
    Katz T; Fisher P; Katz A; Davidson J; Feder G
    Homeopathy; 2005 Jul; 94(3):145-52. PubMed ID: 16060200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.
    Bradwejn J; Ahokas A; Stein DJ; Salinas E; Emilien G; Whitaker T
    Br J Psychiatry; 2005 Oct; 187():352-9. PubMed ID: 16199795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.